1 Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany,
2 Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom,
3 Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark,
4 German Centre for Cardiovascular Research (DZHK), Partner site Munich Heart Alliance, Munich, Germany,
5 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands,
Address for correspondence Anne Rigby, PhD Institute for Cardiovascular Prevention (IPEK) LMU Munich, Munich, Bayern 80336 Germany.
(E-mail: [email protected]).
Christian Weber, MD Institute for Cardiovascular Prevention (IPEK) LMU Munich, Pettenkoferstraβe 9, 80336 Munich Germany [email protected]
Conflict of Interest
G.Y.H.L. reports consultancy and speaker fees from Bayer, Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife, Roche, and Daiichi-Sankyo outside the submitted work. No fees received personally.
Published online: 2020-05-05
received March 25, 2020
accepted March 25, 2020
